Literature DB >> 1973934

The clinical course and long-term management of generalized anxiety disorder.

K Rickels1, E Schweizer.   

Abstract

Evidence suggests that generalized anxiety disorder (GAD) has a fairly chronic course marked by significant long-term distress and comorbidity. Research has focused on short-term treatment of GAD, and long-term outcome studies after either short- or long-term treatment have been relatively neglected. The authors discuss the benefits and risks of various drug and nondrug therapies used in the long-term management of generalized anxiety disorder and suggest avenues for future research.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973934

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  6 in total

Review 1.  Psychological therapies for generalised anxiety disorder.

Authors:  V Hunot; R Churchill; M Silva de Lima; V Teixeira
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 2.  Generalised anxiety disorder: treatment options.

Authors:  John J Sramek; Victoria Zarotsky; Neal R Cutler
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.

Authors:  Alan J Lenox-Smith; Alan Reynolds
Journal:  Br J Gen Pract       Date:  2003-10       Impact factor: 5.386

Review 4.  Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.

Authors:  J R Steinberg
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

5.  Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD).

Authors:  Shiv Gautam; Akhilesh Jain; Manaswi Gautam; Vihang N Vahia; Anita Gautam
Journal:  Indian J Psychiatry       Date:  2017-01       Impact factor: 1.759

6.  Framing the process in the implementation of care for people with generalized anxiety disorder in primary care: a qualitative evidence synthesis.

Authors:  Ana Toledo-Chávarri; Vanesa Ramos-García; Alezandra Torres-Castaño; María M Trujillo-Martín; Wenceslao Peñate Castro; Isabel Del Cura-Castro; Pedro Serrano-Aguilar; Lilisbeth Perestelo-Pérez
Journal:  BMC Fam Pract       Date:  2020-11-20       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.